This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cohen Milstein Sellers & Toll PLLC Announces A Class Action Lawsuit Has Been Filed Against Amedisys, Inc.

A nationwide class action lawsuit was filed yesterday against one the nation’s largest home health care service providers. Filed in the U.S. District Court for the District of Connecticut, the lawsuit asserts that Amedisys, Inc. (NASDAQ: AMED) (“Amedisys”) violates the Fair Labor Standards Act (FLSA), according to plaintiffs’ counsel Christine Webber of Cohen Milstein Sellers & Toll PLLC.

The lawsuit, entitled Cook, et al. v. Amedisys, Inc., asserts that Amedisys, which has more than 16,000 employees, treats visiting nurses and other home health care providers as exempt from the overtime requirements of the FLSA and refuses to pay these employees for all hours worked or time-and-a-half for hours worked over 40 per week. Amedisys pays nurses and other health care providers on a “per visit” basis for some work, with visit rates set based on estimated average visit durations, an hourly rate for other work, and fails to pay anything at all for other hours worked. Plaintiffs allege this compensation scheme does not meet the requirements of state or federal wage and hour law.

Along with Cohen Milstein, attorneys at Martin & Jones, PLLC, and Hayber Law Firm, LLC, have petitioned the court to certify the lawsuit as a nationwide FLSA class action and provide all similarly situated employees notice for an opportunity to join the lawsuit. This would allow all current and former Amedisys registered nurses, physical therapists, occupational therapists, and speech language pathologists who have not been paid for all hours worked to be eligible to participate in this legal action.

“Amedisys’ compensation scheme encourages employees to take on more patient visits, and work longer hours, while Amedisys reaps the benefits by reducing their labor costs and boosting their profit margins,” said Jill Hernandez, who worked more than 10 years as a Wage and Hour Investigator with the U.S. Department of Labor prior to joining Martin & Jones, where she represents employees in violations of both federal and state wage and hour law.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs